Advanced search
Publication Cover
Clinical and Experimental Hypertension Volume 45, 2023 - Issue 1
Submit an article Journal homepage
4,476
Views
0
CrossRef citations to date
0
Altmetric
Research Article

What is the prevalence of chronic kidney disease among hypertensive non-diabetic Egyptian patients attending primary healthcare?

Silvana Nader Nagiba Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, EgyptView further author information
,
Saeed Abdelwahabb Department of Internal Medicine and Nephrology, Faculty of Medicine, Ain Shams University, Cairo, EgyptView further author information
,
Ghada Essam El-Din Amina Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt;c Department of Community, Environment and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, EgyptView further author information
&
Mohamed Farouk Allama Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, EgyptCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5954-8909View further author information
ORCID Icon
Article: 2203411 | Received 13 Jun 2022, Accepted 11 Apr 2023, Published online: 23 Apr 2023

References

  • Yamany A, Shehata H, Essameldin M, Ibrahim S. Screening of incidental kidney disease in normoglycemic, normotensive healthy adults. Egypt J Intern Med. 2017;29:127–6.
  • Tannor EK, Sarfo FS, Mobula LM, Sarfo-Kantanka O, Adu-Gyamfi R, Plange-Rhule J. Prevalence and predictors of chronic kidney disease among Ghanaian patients with hypertension and diabetes mellitus: a multicenter cross sectional study. J Clin Hypertens. 2019;21(5):1542–50. doi:10.1111/jch.13672.
  • Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guidelines. Ann Int Med. 2013;158(11):825–30. doi:10.7326/0003-4819-158-11-201306040-00007.
  • Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089–100. doi:10.1111/j.1523-1755.2005.00365.x.
  • Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379(9811):165–80. doi:10.1016/S0140-6736(11)60178-5.
  • Bao LW, Xie K, Bao LL, Shan Y, Zhuang XY, Shi HM, Li Y, Gao XF. for the UPPDATE collaboration. Diverse association between components of metabolic syndrome and chronic kidney disease in hypertension of different low-density lipoprotein cholesterol levels. Cardiol Plus. 2020;5(9):89–96. doi:10.4103/cp.cp_10_20.
  • Centers for Disease Control and Prevention. Chronic kidney disease in the United States. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention;2021.
  • Gouda Z, Mashaal G, Bello AK, El Attar A, El Kemmry T, El Reweny A, El Nahas M. Egypt information, prevention, and treatment of chronic kidney disease (EGIPT-CKD) programme: prevalence and risk factors for microalbuminuria among the relatives of patients with CKD in Egypt. Saudi J Kidney Dis Transpl. 2011;22(5):1055–63.
  • Soliman AR, Fathy A, Roshd D. The growing burden of end-stage renal disease in Egypt. Ren Fail. 2012;34(4):425–28. doi:10.3109/0886022X.2011.649671.
  • Gaitonde DY, David MD, Cook L, Rivera IM DL, Dwight D. Eisenhower Army Medical Center, Fort Gordon, Georgia. Chronic Kidney Dis. 2017;96(12):776–83.
  • Alemán-Vega G, Gómez Cabañas I, Reques Sastre L, Rosado Martín J, Polentinos-Castro E, Rodríguez Barrientos R. Prevalence and risk of progression of chronic kidney disease in diabetic and hypertensive patients followed in primary care in the community of Madrid. Nephrology. 2017;37(3):343–45. doi:10.1016/j.nefroe.2017.05.010.
  • Mohanty NK, Sahoo KC, Pati S, Sahu AK, Mohanty R. Prevalence of chronic kidney disease in Cuttack District of Odisha, India. Int J Environ Res Public Health. 2020;17(2):456. doi:10.3390/ijerph17020456.
  • da Silva LS, Cotta RM, Moreira TR, da Silva RG, de OB, Rosa C, Machado JC, Bastos MA. Hidden prevalence of chronic kidney disease in hypertensive patients: the strategic role of primary health care. Public Health. 2016;140:250–57. doi:10.1016/j.puhe.2016.02.029.
  • Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, Chen J, He J. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950–57. doi:10.1038/ki.2015.230.
  • Ravi Kumar P, Dongre A, Muruganandham R, Deshmukh P, Rajagovindan D. Prevalence of chronic kidney disease and its determinants in rural Pondicherry, India-a community based cross-sectional study. Open Urol Nephrol J. 2019;12(1):14–22. doi:10.2174/1874303X01912010014.
  • Komaroff M, Tedla F, Helzner E, Joseph MA. Antihypertensive medications and change in stages of chronic kidney disease. Int J Chronic Dis. 2018;25:1–10. doi:10.1155/2018/1382705.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.